213 related articles for article (PubMed ID: 28603410)
1. Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration.
Kabanarou SA; Xirou T; Mangouritsas G; Garnavou-Xirou C; Boutouri E; Gkizis I; Chatziralli I
Clin Interv Aging; 2017; 12():911-915. PubMed ID: 28603410
[TBL] [Abstract][Full Text] [Related]
2. Atypical macular hole formation after Anti-VEGF therapy for neovascular age-related macular degeneration: Coincidence or consequence?
Kayaarasi Ozturker Z; Akca Bayar S; Yaman Pinarci E; Kurt RA; Akkoyun I; Yilmaz G
Arch Soc Esp Oftalmol (Engl Ed); 2021 Sep; 96(9):455-461. PubMed ID: 34479701
[TBL] [Abstract][Full Text] [Related]
3. Vitrectomy for full thickness macular hole developed during the course of anti-VEGF treatment of type 1 neovascular AMD.
Nawrocka ZA; Nawrocka Z; Nawrocki J
Eur J Ophthalmol; 2022 Sep; 32(5):NP5-NP8. PubMed ID: 33740870
[TBL] [Abstract][Full Text] [Related]
4. Macular hole formation in the presence of a pigment epithelial detachment after three consecutive intravitreal antivascular endothelial growth factor injections.
Clemens CR; Holz FG; Meyer CH
J Ocul Pharmacol Ther; 2010 Jun; 26(3):297-9. PubMed ID: 20565318
[TBL] [Abstract][Full Text] [Related]
5. VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Krishnan R; Arora R; De Salvo G; Stinghe A; Severn PS; Pal B; Goverdhan S
Retina; 2015 Sep; 35(9):1750-6. PubMed ID: 26237240
[TBL] [Abstract][Full Text] [Related]
6. Changes in Peripapillary Nerve Fiber Layer Thickness after Adjuvant Stereotactic Radiotherapy in Patients with Neovascular Age-Related Macular Degeneration.
Ranjbar M; Kurz M; Holzhey A; Rades D; Grisanti S
Curr Eye Res; 2017 Dec; 42(12):1698-1706. PubMed ID: 28937877
[TBL] [Abstract][Full Text] [Related]
7. The effect of vitreomacular interface in neovascular age-related macular degeneration treated with intravitreal injection of anti-VEGF.
Han F; Chen X; Zhao R; Jin X; Tan W; Zhang Y
BMC Ophthalmol; 2022 Nov; 22(1):419. PubMed ID: 36329392
[TBL] [Abstract][Full Text] [Related]
8. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANALYSIS OF RETINAL DEGENERATIVE CHANGES IN DIABETIC MACULAR EDEMA AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Boiko EV; Maltsev DS
Retina; 2018 Jul; 38(7):1324-1330. PubMed ID: 28492427
[TBL] [Abstract][Full Text] [Related]
9. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Lee H; Ji B; Chung H; Kim HC
Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
[TBL] [Abstract][Full Text] [Related]
10. Full thickness macular hole case after intravitreal aflibercept treatment.
Oshima Y; Apte RS; Nakao S; Yoshida S; Ishibashi T
BMC Ophthalmol; 2015 Mar; 15():30. PubMed ID: 25881212
[TBL] [Abstract][Full Text] [Related]
11. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration.
Lee SJ; Koh HJ
Ophthalmology; 2011 Jan; 118(1):101-10. PubMed ID: 20678805
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal bevacizumab treatment between phakic and pseudophakic neovascular age-related macular degeneration.
Ozkaya A; Alkin Z; Perente I; Yuksel K; Baz O; Alagoz C; Yazici AT; Demirok A
Nepal J Ophthalmol; 2014; 6(2):145-52. PubMed ID: 25680245
[TBL] [Abstract][Full Text] [Related]
13. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
[TBL] [Abstract][Full Text] [Related]
14. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience of switching anti-VEGF therapy from ranibizumab to aflibercept in age-related choroidal neovascularization.
Van Lancker L; Petrarca R; Moutsouris K; Masaoutis P; Kampougeris G
Eur J Ophthalmol; 2017 May; 27(3):342-345. PubMed ID: 27739561
[TBL] [Abstract][Full Text] [Related]
16. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment
Witkin AJ; Rayess N; Garg SJ; Maguire JI; Storey P; Kaiser RS; Hsu J; Vander JF; Ho AC
Semin Ophthalmol; 2017; 32(3):309-315. PubMed ID: 26337539
[TBL] [Abstract][Full Text] [Related]
17. Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
Cho HJ; Kim JM; Kim HS; Lee DW; Kim CG; Kim JW
J Ocul Pharmacol Ther; 2017; 33(6):452-458. PubMed ID: 28445077
[TBL] [Abstract][Full Text] [Related]
18. [Visual and anatomical outcomes of three intravitreal aflibercept injections in eyes with neovascular form of age-related macular degeneration].
Kałuiny JJ; Majer A; Jaworowska-Cieślińska I
Klin Oczna; 2015; 117(1):9-13. PubMed ID: 26349151
[TBL] [Abstract][Full Text] [Related]
19. Optical Coherence Tomography Monitoring Strategies for A-VEGF-Treated Age-Related Macular Degeneration: An Evidence-Based Analysis.
Pron G
Ont Health Technol Assess Ser; 2014; 14(10):1-64. PubMed ID: 26316918
[TBL] [Abstract][Full Text] [Related]
20. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
Melamud A; Stinnett S; Fekrat S
Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
